Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up

• Egile Nagusiak: Celestino Sardu (Egilea), Massimo Massetti (Egilea), Nicola Testa (Egilea), Luigi Di Martino (Egilea), Gaetano Castellano (Egilea), Fabrizio Turriziani (Egilea), Ferdinando Carlo Sasso (Egilea), Michele Torella (Egilea), Marisa De Feo (Egilea), Gaetano Santulli (Egilea), Giuseppe Paolisso (Egilea), Raffaele Marfella (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Minimally invasive extracorporeal circulation (MiECC) reduced inflammatory burden, leading to best clinical outcomes in patients treated with coronary artery bypass grafting (CABG). Despite this, the patients with type 2 diabetes mellitus (T2DM) vs those without T2DM (non-T2DM) have a...